|
A failing economy is to blame for U.S. patients not
filling their prescriptions, a study by a Philadelphia-based heath
information company suggests.
The study, conducted by Wolters-Kluwer Health,
found U.S. patients did not fill 6.8 percent of the brand-name
prescriptions ordered by physicians in the fourth quarter of 2008, a 22
percent increase over the first quarter of 2007.
Patients treated generics more favorably, failing to fill 4.1 percent of generic prescriptions.
“When it comes to compliance on filling medical
prescriptions, there are two types of people: Those who never fill
them, and those who don’t fill them because they can’t,” said Peter
Pitts, director of New York-based Center for Medicine in the Public
Interest and former associate commissioner of the federal Food and Drug
Administration.
That’s one of the failures of the study, Pitts said.
“The study didn’t break down what percent does have insurance and what percent does not,” Pitts said, “as well as what group qualifies for assistance.
“The statistics presented in this study are only
showing you part of what is going on,” Pitts said. “It is not
dishonest; it just incomplete information, which is a prescription for
disaster.”
“The truth is, the growth in prescription drug
co-payments outpaces the growth of prescription drug prices,” Pitts
said. “The price of co-pay is going up four times [as fast as] the
price of the drug. The problem isn’t with the cost of the drug; the
problem is with the insurance. When co-pay goes down, compliance will
come up.”
According to the report, “generic prescriptions
increased to 2.4 billion in 2008, up 200 million compared with 2007,
while orders for brand-name medicines declined by 200 million for 2008,
to 1.4 billion.”
Shikha Dalmia, a senior policy analyst for the
Reason Foundation based in Washington, DC, said turning to generic
drugs “isn’t necessarily a bad thing” and, “considering the severity of
this recession,” she isn’t too shocked.
“What is bad is if people are forgoing drugs and, therefore, their health gets worse,” Dalmia said.
A better-treated patient, Pitts and Dalmia agreed, is essentially less expensive.
Ultimately, Pitts explained, the results of the study will be used as just “another credit for Uncle Sam.
“This is another piece of information that will be
used to support a massive government takeover. And if you want to
reform health care, we have to look at all of the facts, not just some
of them,” Pitts added.
|